fig1

CAR-T cell therapy in neuro-oncology: applications and toxicity

Figure 1. Multifocal glioblastoma responding to intraventricular delivery of IL13Ra2-redirected CAR T-cell therapy (modified from Brown et al.[28], permission for use granted by NEJM). A: sagittal view of gadolinium-enhanced MRI (top row) and FDG-PET (bottom row) images showing tumor regression of tumors 6 and 7 in the brain (yellow arrowheads and circles); B: sagittal gadolinium-enhanced MRI (top row) and coronal DG-PET (bottom row) images exhibiting tumor regression of tumor 8 in the spine (yellow circles)

Neuroimmunology and Neuroinflammation
ISSN 2349-6142 (Online) 2347-8659 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/